#Abbott Laboratories (ABT)

Abbott Laboratories New PROTALITY™ for Maintaining Muscle Mass During Weight Loss Abbott Laboratories (ABT) announced the launch of its new PROTALITY™ brand. The high-protein nutrition shake is the fi...

While preparing The Week in Review issue from Prohost, our attention  shifted towards historical news about a procedure that improved the heart function in severe heart failure patients. For cardiolog...

Medivation is a Target for Acquisition The Question is: Who Will Acquire Medivation? Sanofi  has made a bid to acquire Medivation for $9.3 billion (£6.37B ). Sanofi is expected to pay $52.50 per share...

Sequenom (SQNM) ,  the firm that fell victim to third party reimbursement problems, to an irrelevant dispute around its Down syndrome test patent and to overwhelming expenses. Investors might have rec...

With the Biotech Index rising tremendously year to date, We find it a loss of time writing about failures in clinical data coming from some firms we have nothing to do with, or have divorced long ago,...

The HCV market is growing huge – 20 billion and the competing drugs are not numerous, but the results of all-oral treatments are showing safety and efficacy at Gilead (GILD) and Abbott (ABT) today and...

Pharmacyclics® Triggers Another Significant Milestone Payment for Phase III Chronic Lymphocytic Leukemia Combination Trial PHARMACYCLICS (PCYC)  announced that the international, randomized Phase 3 cl...